Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Colorectal Neoplasms | 9 | 2024 | 253 | 1.820 |
Why?
|
| Ileus | 1 | 2023 | 15 | 0.910 |
Why?
|
| Colonic Neoplasms | 1 | 2023 | 158 | 0.800 |
Why?
|
| Abdominal Muscles | 1 | 2021 | 14 | 0.750 |
Why?
|
| Neuromuscular Blockade | 1 | 2021 | 11 | 0.750 |
Why?
|
| Anesthesia, Conduction | 1 | 2021 | 16 | 0.740 |
Why?
|
| Colectomy | 3 | 2024 | 34 | 0.670 |
Why?
|
| Length of Stay | 1 | 2021 | 623 | 0.590 |
Why?
|
| Early Detection of Cancer | 3 | 2020 | 163 | 0.430 |
Why?
|
| ABO Blood-Group System | 1 | 2012 | 15 | 0.430 |
Why?
|
| Colorectal Surgery | 2 | 2023 | 17 | 0.410 |
Why?
|
| Patient Readmission | 2 | 2024 | 221 | 0.400 |
Why?
|
| Registries | 2 | 2024 | 522 | 0.390 |
Why?
|
| Mass Screening | 3 | 2020 | 346 | 0.390 |
Why?
|
| Quality Assurance, Health Care | 1 | 2011 | 149 | 0.360 |
Why?
|
| Laparoscopy | 1 | 2011 | 170 | 0.330 |
Why?
|
| Retrospective Studies | 6 | 2023 | 6106 | 0.310 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2020 | 105 | 0.280 |
Why?
|
| Vitamin B Complex | 1 | 2024 | 21 | 0.240 |
Why?
|
| Female | 14 | 2024 | 26520 | 0.240 |
Why?
|
| Choline | 1 | 2024 | 63 | 0.240 |
Why?
|
| Male | 13 | 2024 | 25439 | 0.240 |
Why?
|
| Anastomotic Leak | 1 | 2023 | 10 | 0.230 |
Why?
|
| Intestinal Obstruction | 1 | 2023 | 36 | 0.210 |
Why?
|
| Humans | 16 | 2024 | 49863 | 0.210 |
Why?
|
| Middle Aged | 10 | 2024 | 12258 | 0.210 |
Why?
|
| Aged | 8 | 2024 | 9434 | 0.200 |
Why?
|
| Case-Control Studies | 2 | 2024 | 1129 | 0.200 |
Why?
|
| Insurance Coverage | 2 | 2024 | 109 | 0.190 |
Why?
|
| Pesticides | 1 | 2021 | 18 | 0.190 |
Why?
|
| Hospitals, Teaching | 1 | 2021 | 53 | 0.180 |
Why?
|
| Arkansas | 3 | 2024 | 1982 | 0.180 |
Why?
|
| Diet | 1 | 2024 | 555 | 0.180 |
Why?
|
| Narcotics | 1 | 2021 | 108 | 0.180 |
Why?
|
| Ultrasonography, Mammary | 1 | 2020 | 61 | 0.180 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2021 | 115 | 0.170 |
Why?
|
| Occupational Exposure | 1 | 2021 | 112 | 0.170 |
Why?
|
| Adult | 6 | 2024 | 13325 | 0.170 |
Why?
|
| Healthcare Disparities | 2 | 2024 | 277 | 0.160 |
Why?
|
| Incidence | 3 | 2021 | 982 | 0.160 |
Why?
|
| Neoplasm Staging | 3 | 2020 | 748 | 0.150 |
Why?
|
| Sacrum | 1 | 2018 | 18 | 0.150 |
Why?
|
| Mandatory Programs | 1 | 2018 | 21 | 0.150 |
Why?
|
| Spinal Neoplasms | 1 | 2018 | 30 | 0.150 |
Why?
|
| Orthopedic Procedures | 1 | 2018 | 67 | 0.150 |
Why?
|
| Lumbar Vertebrae | 1 | 2018 | 97 | 0.140 |
Why?
|
| Postoperative Complications | 1 | 2023 | 1000 | 0.140 |
Why?
|
| Hospitalization | 1 | 2021 | 663 | 0.140 |
Why?
|
| Survival Rate | 2 | 2017 | 904 | 0.130 |
Why?
|
| Physicians | 1 | 2018 | 227 | 0.120 |
Why?
|
| Neoplasms | 1 | 2023 | 1233 | 0.110 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2013 | 19 | 0.110 |
Why?
|
| Rectum | 1 | 2013 | 52 | 0.110 |
Why?
|
| Rural Population | 1 | 2017 | 546 | 0.100 |
Why?
|
| Rectal Neoplasms | 1 | 2013 | 51 | 0.100 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2013 | 124 | 0.100 |
Why?
|
| Combined Modality Therapy | 1 | 2014 | 638 | 0.100 |
Why?
|
| Logistic Models | 2 | 2024 | 895 | 0.100 |
Why?
|
| Academic Medical Centers | 1 | 2012 | 147 | 0.100 |
Why?
|
| Breast Neoplasms | 1 | 2020 | 1181 | 0.100 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2012 | 463 | 0.100 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 577 | 0.090 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 3132 | 0.070 |
Why?
|
| Risk Factors | 2 | 2024 | 3597 | 0.070 |
Why?
|
| United States | 3 | 2023 | 4870 | 0.060 |
Why?
|
| Poverty Areas | 1 | 2024 | 37 | 0.060 |
Why?
|
| Colonoscopy | 1 | 2024 | 96 | 0.060 |
Why?
|
| Ghana | 1 | 2023 | 4 | 0.060 |
Why?
|
| Insurance, Health | 1 | 2024 | 131 | 0.060 |
Why?
|
| Odds Ratio | 1 | 2024 | 547 | 0.050 |
Why?
|
| Poverty | 1 | 2024 | 207 | 0.050 |
Why?
|
| Fellowships and Scholarships | 1 | 2023 | 116 | 0.050 |
Why?
|
| Patient Selection | 1 | 2023 | 253 | 0.050 |
Why?
|
| Pesticide Residues | 1 | 2021 | 7 | 0.050 |
Why?
|
| Herbicides | 1 | 2021 | 11 | 0.050 |
Why?
|
| Databases, Factual | 1 | 2024 | 660 | 0.050 |
Why?
|
| Research Design | 1 | 2023 | 343 | 0.050 |
Why?
|
| Democratic Republic of the Congo | 1 | 2020 | 4 | 0.050 |
Why?
|
| Dietary Supplements | 1 | 2024 | 435 | 0.050 |
Why?
|
| Image-Guided Biopsy | 1 | 2020 | 33 | 0.050 |
Why?
|
| Biopsy, Large-Core Needle | 1 | 2020 | 31 | 0.050 |
Why?
|
| Cohort Studies | 1 | 2024 | 1400 | 0.040 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2020 | 108 | 0.040 |
Why?
|
| Breast | 1 | 2020 | 86 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2024 | 1253 | 0.040 |
Why?
|
| Ultrasonography, Interventional | 1 | 2020 | 137 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2020 | 382 | 0.040 |
Why?
|
| Occult Blood | 1 | 2017 | 22 | 0.040 |
Why?
|
| Morbidity | 1 | 2018 | 128 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 1038 | 0.040 |
Why?
|
| Rural Health | 1 | 2017 | 88 | 0.040 |
Why?
|
| Biopsy | 1 | 2018 | 591 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2018 | 583 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 2174 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 855 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 1180 | 0.020 |
Why?
|
| Prognosis | 1 | 2013 | 1948 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2018 | 5165 | 0.020 |
Why?
|